BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18380914)

  • 41. The effect of ion-pair formation combined with penetration enhancers on the skin permeation of loxoprofen.
    Hui M; Quan P; Yang Y; Fang L
    Drug Deliv; 2016 Jun; 23(5):1550-7. PubMed ID: 25386739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats.
    Huang JM; Weng WY; Huang XB; Ji YH; Chen E
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):165-70. PubMed ID: 16250252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers.
    Meidan VM; Al-Khalili M; Michniak BB
    Int J Pharm; 2003 Oct; 264(1-2):73-83. PubMed ID: 12972337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism profile of scutellarin in urine following oral administration to rats by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry.
    Liu Q; Shi Y; Wang Y; Lu J; Cong W; Luo G; Wang Y
    Talanta; 2009 Nov; 80(1):84-91. PubMed ID: 19782195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.
    Merino V; Micó-Albiñana T; Nácher A; Díez-Sales O; Herráez M; Merino-Sanjuán M
    J Pharm Pharmacol; 2008 Apr; 60(4):415-20. PubMed ID: 18380912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
    Liu H; Li S; Wang Y; Yao H; Zhang Y
    Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. l-Menthol, oleic acid and lauricidin in absorption enhancement of free and sodium salt of diclofenac using ethanol treated silicone membrane as model for skin.
    Maitani Y; Shimada K; Nagai T
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):403-8. PubMed ID: 8998843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transdermal delivery of zalcitabine: in vitro skin permeation study.
    Kim DD; Chien YW
    AIDS; 1995 Dec; 9(12):1331-6. PubMed ID: 8605052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of ion pairing on the skin permeation of amlodipine.
    Jiang Y; Fang L; Niu X; Rui M; He Z
    Pharmazie; 2008 May; 63(5):356-60. PubMed ID: 18557419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
    Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
    Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the absorption enhancer, Azone, on the transport of 5-fluorouracil across hairless rat skin.
    Sugibayashi K; Hosoya K; Morimoto Y; Higuchi WI
    J Pharm Pharmacol; 1985 Aug; 37(8):578-80. PubMed ID: 2864423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of aglycone conjugated metabolites of scutellarin in rat plasma by HPLC.
    Huang J; Li N; Yu Y; Weng W; Huang X
    J Pharm Biomed Anal; 2006 Feb; 40(2):465-71. PubMed ID: 16181763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique.
    Goodman M; Barry BW
    J Invest Dermatol; 1988 Oct; 91(4):323-7. PubMed ID: 3171212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
    Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
    Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion.
    Kamal MA; Iimura N; Nabekura T; Kitagawa S
    Chem Pharm Bull (Tokyo); 2007 Mar; 55(3):368-71. PubMed ID: 17329873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane.
    Takahashi K; Rytting JH
    J Pharm Pharmacol; 2001 Jun; 53(6):789-94. PubMed ID: 11428654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanistic investigation and reversible effect of 2-isopropyl-5-methylcyclohexyl heptanoate on the in vitro percutaneous absorption of indomethacin.
    Jiang J; Quan P; Chen Y; Fang L
    Drug Deliv; 2014 Feb; 21(1):26-33. PubMed ID: 24134638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Advances in studies on pharmacokinetics of scutellarin and scutellarein].
    Liu J; Xiong Y
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3165-8. PubMed ID: 20352990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives.
    Sato S; Hirotani Y; Ogura N; Sasaki E; Kitagawa S
    Chem Pharm Bull (Tokyo); 1998 May; 46(5):831-6. PubMed ID: 9621418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of chemical enhancers in the transdermal delivery of lidocaine.
    Lee PJ; Ahmad N; Langer R; Mitragotri S; Prasad Shastri V
    Int J Pharm; 2006 Feb; 308(1-2):33-9. PubMed ID: 16321488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.